Methyl Aminolevulinate-photodynamic Therapy for Basal Cell Carcinoma

Dermatologic Clinics

Volumn 25, Issue 1, 2007, Pages 89-94

  Szeimies, Rolf Markus ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; AMINOLEVULINIC ACID METHYL ESTER; BENZOPORPHYRIN DERIVATIVE; PHOTOFRIN; PHOTOSENSITIZING AGENT; TETRAKIS(3 HYDROXYPHENYL)CHLORIN;

BASAL CELL CARCINOMA; CANCER RECURRENCE; CLINICAL TRIAL; CRYOTHERAPY; CYTOREDUCTIVE SURGERY; DRUG EFFICACY; DRUG PENETRATION; DRUG TOLERABILITY; ERYTHEMA; FOLLOW UP; HISTOPATHOLOGY; HUMAN; PAIN; PHOTODYNAMIC THERAPY; PHOTOTOXICITY; PRIORITY JOURNAL; REVIEW; SURGICAL TECHNIQUE; TREATMENT OUTCOME; TREATMENT PLANNING;

AMINOLEVULINIC ACID; CARCINOMA, BASAL CELL; HUMANS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; SKIN NEOPLASMS;

EID: 33751178829     PISSN: 07338635     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.det.2006.09.008     Document Type: Review

References (19)

1. Morton C.A., Brown S.B., Collins S., et al. Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group. Br J Dermatol 146 (2002) 552-567
2. Szeimies R.M., Morton C.A., Sidoroff A., et al. Photodynamic therapy for non-melanoma skin cancer. Acta Derm Venereol 85 (2005) 483-490
3. Wilson B.D., Mang T.S., Stoll H., et al. Photodynamic therapy for the treatment of basal cell carcinoma. Arch Dermatol 128 (1992) 1597-1601
4. Lui H., Hobbs L., Tope W.D., et al. Photodynamic therapy of multiple nonmelanoma skin cancers with verteporfin and red light-emitting diodes: two-year results evaluating tumor response and cosmetic outcomes. Arch Dermatol 140 (2004) 26-32
5. Baas P., Saarnak A.E., Oppelaar H., et al. Photodynamic therapy with meta-tetrahydroxyphenylchlorin for basal cell carcinoma: a phase I/II study. Br J Dermatol 145 (2001) 75-78
6. Peng Q., Soler A.M., Warloe T., et al. Selective distribution of porphyrins in skin thick basal cell carcinoma after topical application of methyl 5-aminolevulinate. J Photochem Photobiol B 62 (2001) 140-145
7. Horn M., Wolf P., Wulf H.C., et al. Topical methyl aminolevulinate photodynamic therapy in patients with basal cell carcinoma prone to complications and poor cosmetic outcome with conventional therapy. Br J Dermatol 149 (2003) 1242-1249
8. Vinciullo C., Elliott T., Francis D., et al. Photodynamic therapy with topical aminlaevulinate for 'difficult-to-treat' basal cell carcinoma. Br J Dermatol 152 (2005) 765-772
9. Rhodes L.E., de Rie M., Enstrom Y., et al. Photodynamic therapy using topical methyl aminolevulinate vs surgery for nodular basal cell carcinoma: results of a multicenter randomized prospective trial. Arch Dermatol 140 (2004) 17-23
10. Tope W.D., Menter A., El-Azhary R.A., et al. Comparison of topical methyl aminolevulinate photodynamic therapy versus placebo photodynamic therapy in nodular BCC. J Eur Acad Dermatol Venereol 18 (2004) 413-414
11. Foley P, Freeman M, Siller G, et al. MAL-PDT or placebo cream in nodular basal cell carcinoma: results of an Australian double blind randomized multicentre study [poster]. Presented at the International Skin Cancer Conference, Zurich, July 22-24, 2004.
12. Soler A.M., Warloe T., Tausjo J., et al. Photodynamic therapy by topical aminolevulinic acid, dimethylsulphoxide and curettage in nodular basal cell carcinoma: a one-year follow-up study. Acta Derm Venereol 79 (1999) 204-206
13. Thissen M.R., Schroeter C.A., and Neumann H.A. Photodynamic therapy with delta-aminolaevulinic acid for nodular basal cell carcinomas using a prior debulking technique. Br J Dermatol 142 (2000) 338-339
14. Calzavara-Pinton P.G. Repetitive photodynamic therapy with topical delta-aminolaevulinic acid as an appropriate approach to the routine treatment of superficial non-melanoma skin tumours. J Photochem Photobiol B 29 (1995) 53-57
15. Svanberg K., Andersson T., Killander D., et al. Photodynamic therapy of non-melanoma malignant tumours of the skin using topical delta-amino levulinic acid sensitization and laser irradiation. Br J Dermatol 130 (1994) 743-751
16. Braathen LR, Szeimies RM, Basset-Seguin N, et al. Guidelines on the use of photodynamic therapy (PDT) for non-melanoma skin cancer- an international consensus. J Am Acad Dermatol, in press.
17. Soler A.M., Warloe T., Berner A., et al. A follow-up study of recurrence and cosmesis in completely responding superficial and nodular basal cell carcinomas treated with methyl 5-aminolaevulinate-based photodynamic therapy alone and with prior curettage. Br J Dermatol 145 (2001) 467-471
18. Wang I., Bendsoe N., Klinteberg C.A., et al. Photodynamic therapy vs. cryosurgery of basal cell carcinomas: results of a phase III clinical trial. Br J Dermatol 144 (2001) 832-840
19. Basset-Seguin N., Ibbotson S., Emtestam L., et al. Photodynamic therapy using Metvix is as efficacious as cryotherapy in BCC, with better cosmetic results. J Eur Acad Dermatol Venereol 18 (2004) 412